Amgen

8 Stories

Medicare Will Target These 10 Drugs for Price Cuts

Biden administration to negotiate 'lowest maximum fair price' for Jardiance, Eliquis, others

(Newser) - The popular diabetes treatment Jardiance and the blood thinner Eliquis are among the first drugs that will be targeted for price negotiations in an effort to cut Medicare costs, reports the AP . President Biden's administration on Tuesday released a list of 10 drugs for which the federal government will...

New Cancer Drug May Offer Alternative to Chemo

Amgen's KRAS-targeting drug showed strong results, but it's pricey

(Newser) - Chemotherapy, known as much for its toxic side effects as its cancer-fighting prowess, may have some serious competition. Per the Wall Street Journal, biopharma giant Amgen released significant new data from a study of Lumakras, which last year became the first drug of its kind to gain FDA approval. The...

A Shift in Alzheimer's Strategy: Prevention

2 new studies aim to prevent early plaque formation

(Newser) - It may be too late to stop Alzheimer's in people who already have some mental decline. But what if a treatment could target the earliest brain changes while memory and thinking skills are still intact, in hope of preventing the disease? Two big studies are going to try, per...

Experimental Drug Makes High Cholesterol Vanish

Three companies in mad dash in what could be a huge breakthrough: NY Times

(Newser) - Might high cholesterol one day be a thing of the past? A story in the New York Times about an experimental drug suggests as much. Three companies—Amgen, Pfizer and Sanofi—are racing to complete tests and gain approval for their own version. The drug mimics a rare genetic mutation...

How CEO Pay Spirals Out of Control

Peer benchmarking drives everyone higher

(Newser) - Amgen didn’t do terribly well under CEO Kevin Sharer last year—it eliminated some 2,700 jobs and its stock fell 3%. Yet Sharer pocketed a 37% raise, bringing his compensation to $21 million. Why? Because the board decided he should be paid “closer to the 75th percentile...

Madoff Fund Made No Trades
 Madoff Fund Made No Trades 
Jan 16, 2009 2:35 AM CST

Madoff Fund Made No Trades

Records of trades don't match stock prices

(Newser) - The fund run by Wall Street swindler Bernie Madoff apparently did not execute a single trade the entire time it was raking in billions of dollars in investment cash from unsuspecting clients, reports Reuters. Monthly statements of trades from Madoff were pure fiction that kept up appearances in the $50...

Biotech Giant Slashes Jobs
Biotech Giant Slashes Jobs
Aug 16, 2007 1:34 AM CDT

Biotech Giant Slashes Jobs

World biggest biotech cuts 2,600 jobs in $2B restructuring

(Newser) - Biotech giant Amgen is slashing spending by $1.9 billion by cutting up to 14 percent of its workforce— 2,600 jobs—and closing some production facilities. The restructuring was triggered by plummeting sales of the company's anemia drug Aranesp. The shake up demonstrates that biotech operations are not immune...

Doctors Paid Millions To Use Anemia Drugs

Among the world's top-selling medicines, the FDA now says they may be unsafe

(Newser) - Doctors are paid millions of dollars by drug companies to give their patients anemia medicine which regulators now say may be dangerous. Spurred by competiton between several similar drugs, companies reward doctors with rebates, which allow them to make a significant profit, the New York Times reports.

8 Stories
Most Read on Newser